166 related articles for article (PubMed ID: 20594408)
1. Amphiphilic block co-polyesters bearing pendant cyclic ketal groups as nanocarriers for controlled release of camptothecin.
Wang X; Gurski LA; Zhong S; Xu X; Pochan DJ; Farach-Carson MC; Jia X
J Biomater Sci Polym Ed; 2011; 22(10):1275-98. PubMed ID: 20594408
[TBL] [Abstract][Full Text] [Related]
2. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
3. Poly(ε-caprolactone)-based copolymers bearing pendant cyclic ketals and reactive acrylates for the fabrication of photocrosslinked elastomers.
Yang X; Cui C; Tong Z; Sabanayagam CR; Jia X
Acta Biomater; 2013 Sep; 9(9):8232-44. PubMed ID: 23770222
[TBL] [Abstract][Full Text] [Related]
4. Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers.
Vassiliou AA; Papadimitriou SA; Bikiaris DN; Mattheolabakis G; Avgoustakis K
J Control Release; 2010 Dec; 148(3):388-95. PubMed ID: 20869413
[TBL] [Abstract][Full Text] [Related]
5. Effect of structural factors on release profiles of camptothecin from block copolymer conjugates with high load of drug.
Plichta A; Kowalczyk S; Olędzka E; Sobczak M; Strawski M
Int J Pharm; 2018 Mar; 538(1-2):231-242. PubMed ID: 29341920
[TBL] [Abstract][Full Text] [Related]
6. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation.
Shah M; Ullah N; Choi MH; Kim MO; Yoon SC
Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562
[TBL] [Abstract][Full Text] [Related]
7. Functionalized hydrophobic poly(glycerol-co-ε-caprolactone) depots for controlled drug release.
Wolinsky JB; Yohe ST; Colson YL; Grinstaff MW
Biomacromolecules; 2012 Feb; 13(2):406-11. PubMed ID: 22242897
[TBL] [Abstract][Full Text] [Related]
8. Novel self-assembled amphiphilic poly(epsilon-caprolactone)-grafted-poly(vinyl alcohol) nanoparticles: hydrophobic and hydrophilic drugs carrier nanoparticles.
Sheikh FA; Barakat NA; Kanjwal MA; Aryal S; Khil MS; Kim HY
J Mater Sci Mater Med; 2009 Mar; 20(3):821-31. PubMed ID: 19020953
[TBL] [Abstract][Full Text] [Related]
9. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles.
Kunii R; Onishi H; Ueki K; Koyama K; Machida Y
Drug Deliv; 2008 Jan; 15(1):3-10. PubMed ID: 18197517
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery.
Li F; Danquah M; Mahato RI
Biomacromolecules; 2010 Oct; 11(10):2610-20. PubMed ID: 20804201
[TBL] [Abstract][Full Text] [Related]
11. Folate-decorated and reduction-sensitive micelles assembled from amphiphilic polymer-camptothecin conjugates for intracellular drug delivery.
Liu C; Yuan J; Luo X; Chen M; Chen Z; Zhao Y; Li X
Mol Pharm; 2014 Nov; 11(11):4258-69. PubMed ID: 25238329
[TBL] [Abstract][Full Text] [Related]
12. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
Aluri R; Jayakannan M
Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy.
Huang C; Neoh KG; Xu L; Kang ET; Chiong E
Biomacromolecules; 2012 Aug; 13(8):2513-20. PubMed ID: 22793172
[TBL] [Abstract][Full Text] [Related]
14. Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery.
Liu J; Jiang Z; Zhang S; Saltzman WM
Biomaterials; 2009 Oct; 30(29):5707-19. PubMed ID: 19632718
[TBL] [Abstract][Full Text] [Related]
15. Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles.
Hu Y; Jiang X; Ding Y; Zhang L; Yang C; Zhang J; Chen J; Yang Y
Biomaterials; 2003 Jun; 24(13):2395-404. PubMed ID: 12699677
[TBL] [Abstract][Full Text] [Related]
16. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
[TBL] [Abstract][Full Text] [Related]
17. Amphiphilic star PEG-Camptothecin conjugates for intracellular targeting.
Omar R; Bardoogo YL; Corem-Salkmon E; Mizrahi B
J Control Release; 2017 Jul; 257():76-83. PubMed ID: 27677603
[TBL] [Abstract][Full Text] [Related]
18. Ketal containing amphiphilic block copolymer micelles as pH-sensitive drug carriers.
Lee I; Park M; Kim Y; Hwang O; Khang G; Lee D
Int J Pharm; 2013 May; 448(1):259-66. PubMed ID: 23524123
[TBL] [Abstract][Full Text] [Related]
19. Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.
Mohanty AK; Dilnawaz F; Mohanty C; Sahoo SK
Drug Deliv; 2010 Jul; 17(5):330-42. PubMed ID: 20370380
[TBL] [Abstract][Full Text] [Related]
20. Osmotic pressure driven protein release from viscous liquid, hydrophobic polymers based on 5-ethylene ketal ε-caprolactone: potential and mechanism.
Babasola IO; Zhang W; Amsden BG
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):765-72. PubMed ID: 23665446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
